|
FOXM1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64424029946986E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.01220000003899E-06 |
| Normal-vs-Stage3 |
1.212980E-04 |
| Normal-vs-Stage4 |
5.377000E-04 |
| Stage1-vs-Stage2 |
9.449000E-01 |
| Stage1-vs-Stage3 |
6.228300E-02 |
| Stage1-vs-Stage4 |
1.259690E-02 |
| Stage2-vs-Stage3 |
8.276200E-02 |
| Stage2-vs-Stage4 |
1.436470E-02 |
| Stage3-vs-Stage4 |
1.529170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.59090576454946E-13 |
| Normal-vs-AfricanAmerican |
5.75299999999723E-05 |
| Normal-vs-Asian |
1.285020E-01 |
| Caucasian-vs-AfricanAmerican |
1.417980E-02 |
| Caucasian-vs-Asian |
7.246000E-01 |
| AfricanAmerican-vs-Asian |
3.493000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.16050000112489E-09 |
| Normal-vs-Female |
2.22044604925031E-16 |
| Male-vs-Female |
7.130100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.743750E-03 |
| Normal-vs-Age(41-60Yrs) |
3.58820000000426E-05 |
| Normal-vs-Age(61-80Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(81-100Yrs) |
1.398590E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.678000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.761200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.346200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.852200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.127350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.340300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.76270000000245E-05 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
1.65190000012139E-07 |
| Normal-vs-Grade 4 |
6.216500E-04 |
| Grade 1-vs-Grade 2 |
1.046240E-01 |
| Grade 1-vs-Grade 3 |
9.100200E-03 |
| Grade 1-vs-Grade 4 |
5.503500E-03 |
| Grade 2-vs-Grade 3 |
5.212200E-02 |
| Grade 2-vs-Grade 4 |
1.034030E-02 |
| Grade 3-vs-Grade 4 |
4.814200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
5.42479999809942E-08 |
| ccA subtype-vs-ccB subtype |
5.754700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.22939999999983E-06 |
| Normal-vs-N1 |
7.239700E-04 |
| N0-vs-N1 |
5.602400E-02 |
|
|
